Overvalued to undervalued.
About 175MM in free cash flow for 2021. 12.5% growth over 2020.
Even a modest growth or near term slow down, intrinsic value is about at $50 a share, more time and average growth rates is pushing $60/ share by 2023.
Very smart management, evidenced by the doubling of convertible notes issue in August 2020, sold at the top when the price was 3x what it is now.
This is the vast majority of the liabilities, so recent downtrend fundamentally helps tremendously in this regard.
Technically very strong. Sellers in full control pushed the price to under supports established in early & late 2019 when the business was a fraction of what it is today.
Head and shoulders target was about 30. Overextended.
Most oversold on RSI in company history.
Large gap to fill between 40 - 55.
Long at 25 and adding below, target to sell at 50 - 60. with a 1.5 year holding period.
Growth at a very reasonable price.
About 175MM in free cash flow for 2021. 12.5% growth over 2020.
Even a modest growth or near term slow down, intrinsic value is about at $50 a share, more time and average growth rates is pushing $60/ share by 2023.
Very smart management, evidenced by the doubling of convertible notes issue in August 2020, sold at the top when the price was 3x what it is now.
This is the vast majority of the liabilities, so recent downtrend fundamentally helps tremendously in this regard.
Technically very strong. Sellers in full control pushed the price to under supports established in early & late 2019 when the business was a fraction of what it is today.
Head and shoulders target was about 30. Overextended.
Most oversold on RSI in company history.
Large gap to fill between 40 - 55.
Long at 25 and adding below, target to sell at 50 - 60. with a 1.5 year holding period.
Growth at a very reasonable price.
評論:
Just got a Form 4 from the CEO, after he sold the overvalued top at 100, is starting to re-buy at undervalued lows. Very value competent management here.